From: Survival outcomes for first-line antiretroviral therapy in India’s ART program
Andhra Pradesh and Telangana (N = 3,340)a | Rajasthan (N = 3,241)b | |||
---|---|---|---|---|
Variables | Total (% of N) | Deceased (%) | Total (% of N) | Deceased (%) |
Patient level | ||||
Year of ART initiationc | ||||
2007-08 | 365 (10.9) | 58 (15.9) | ||
2008-09 | 458 (13.7) | 68 (14.9) | 422 (13.0) | 72 (17.1) |
2009-10 | 767 (23.0) | 97 (12.7) | 651 (20.1) | 67 (10.3) |
2010-11 | 829 (24.8) | 124 (15.0) | 749 (23.1) | 90 (12.0) |
2011-12 | 919 (27.5) | 90 (9.8) | 850 (26.2) | 85 (10.0) |
2012-13 | 569 (17.6) | 79 (13.9) | ||
Sex of patient | ||||
Male | 1,724 (51.6) | 273 (15.8) | 1,860 (57.4) | 285 (15.3) |
Female | 1,561 (46.7) | 159 (10.2) | 1,360 (42.0) | 108 (7.9) |
Age of patients (years) | ||||
16–29 | 857 (25.7) | 98 (11.4) | 720 (22.2) | 66 (9.2) |
30–49 | 2,152 (64.4) | 287 (13.3) | 2,250 (69.4) | 278 (12.4) |
= >50 | 329 (9.9) | 52 (15.8) | 271 (8.4) | 49 (18.1) |
CD4 count at ART initiation (cells/mm3) | ||||
< =100 | 782 (23.4) | 168 (21.5) | 954 (29.4) | 209 (21.9) |
101–250 | 1,870 (56.0) | 226 (12.1) | 1,562 (48.2) | 150 (9.6) |
>250 | 659 (19.7) | 41 (6.2) | 696 (21.5) | 31 (4.5) |
Co-existing tuberculosis | ||||
No | 2,823 (84.5) | 336 (11.9) | 2,582 (79.7) | 276 (10.7) |
Yes | 515 (15.4) | 101 (19.6) | 627 (19.4) | 117 (18.7) |
Ever use of alcohol | ||||
No | 2,739 (82.0) | 319 (11.7) | 2,709 (83.6) | 299 (11.0) |
Yes | 599 (17.9) | 118 (19.7) | 519 (16.0) | 94 (18.1) |
Baseline ART regimend | ||||
STV based regimen with/without EFV | 1,377 (41.2) | 215 (15.6) | 832 (25.7) | 146 (17.6) |
ZDV based regimen with/without EFV | 1,542 (46.2) | 166 (10.8) | 2,131 (65.8) | 205 (9.6) |
Facility level variables | ||||
Cumulative ART patient loade | ||||
Below or equal to state average | 1,891 (56.6) | 262 (13.9) | 1,621 (50.0) | 190 (11.7) |
Above state average | 1,449 (43.4) | 175 (12.1) | 1,620 (50.0) | 203 (12.5) |
Ratio of cumulative ART patients to pre-ART patientsf | ||||
Below or equal to state average | 1,998 (59.8) | 275 (13.8) | 2,433 (75.1) | 271 (11.1) |
Above state average | 1,342 (40.2) | 162 (12.1) | 808 (24.9) | 122 (15.1) |
Percent of cumulative loss to follow-up patients g | ||||
Category 1 | 1,070 (32.0) | 123 (11.5) | 1,352 (41.7) | 174 (12.9) |
Category 2 | 1,090 (32.6) | 148 (13.4) | 1,375 (42.4) | 150 (10.9) |
Category 3 | 1,180 (35.3) | 166 (14.1) | 514 (15.9) | 69 (13.4) |